News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
82
Sources here
16
Companies here
4
Search results Stored financial headlines

Active search

82 matching headlines

Ticker or company: NSYSMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Nortech Systems Inc (NSYS) Financial Health: Profitability & Balance Sheet Analysis

Nortech Systems Inc (NSYS) currently has a weak financial status with an average operating efficiency, scoring 7.52 and ranking 46 out of 104 in the Semiconductors & Semiconductor Equipment industry. The company recently reported a 12.72% year-over-year increase in quarterly revenue, reaching $30.32 million, …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NSYS|Nortech Systems Inc|Price:14.455|Chg%:-0.575

This article provides a detailed financial overview and market analysis for Nortech Systems Inc (NSYS). It highlights the company's relatively stable fundamentals, high growth potential, and fair valuation within the Semiconductors & Semiconductor Equipment industry. Key data points include stock performance, financial indicators, institutional …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey attempts to provide a revenue breakdown for Nortech Systems Inc (NSYS) but states that the relevant data has not been disclosed by the company. Consequently, no information on revenue by business segment or by region is available.

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Inc (ENSC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides an overview of Ensysce Biosciences Inc (ENSC) stock data, including its current price, market cap, and P/E TTM. It highlights that detailed revenue breakdown by business segments and regions for ENSC has not yet been disclosed by the company. …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Nortech Systems Inc (NSYS) shareholder structure, listing major shareholders and their proportions, as well as institutional holdings over several reporting periods. Key individual and corporate investors are highlighted, along with changes in their shareholdings. The data also …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Inc (ENSC) Institutional Confidence

This article provides an "Institutional Confidence" score for Ensysce Biosciences Inc (ENSC) as part of TradingKey's stock analysis. The current score is 3.00 with no change from the previous score, and it lists key institutional shareholders along with their shareholdings and recent activity percentage …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Cash Flow

This article provides a comprehensive overview of Nortech Systems Inc's (NSYS) cash flow statements, including operating, investing, and financing activities, presented in both quarterly and annual formats. It details various components such as net income, capital expenditures, and changes in working capital, allowing for …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on Nortech Systems Inc (NSYS) dividends and stock splits. It notes that a total of $0.00 has been distributed in dividends over the past five years by the company. The page indicates no historical dividend data is available.

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Inc (ENSC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Ensysce Biosciences Inc (ENSC). It notes that the company has distributed no dividends over the past five years. However, it lists several stock merger events, including a 15-for-1 merger scheduled for December …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Inc (ENSC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Ensysce Biosciences Inc (ENSC), outlining its major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and recent shareholder activity with changes in holdings for key investors.

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Income Statement

This article provides the quarterly and annual income statements for Nortech Systems Inc (NSYS), covering several years of financial data. It details revenue, cost of revenue, operating expenses, operating profit, net non-operating interest, income before tax, income tax, and net income, along with earnings …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Incorporated Revenue Breakdown – NASDAQ:NSYS

This page provides financial information for Nortech Systems Incorporated (NASDAQ: NSYS) on TradingView. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment performance. The content is primarily a financial data portal and does not contain a traditional article …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Valuation: PE, PB & Fair Value Analysis

Nortech Systems Inc (NSYS) currently holds a valuation score of 9.08, placing it 20th out of 105 companies in the Semiconductors & Semiconductor Equipment industry. The company's P/E ratio stands at 38.13, which is significantly higher than its recent low and slightly below its …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Nortech Systems Inc (NSYS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nortech Systems Inc (NSYS), focusing on its support and resistance levels, various technical indicators, and moving averages. NSYS currently has a price momentum score of 4.40 and is trading between a resistance level of 16.33 and a …

NSYS main company
Sharemaestro market context Trend signal active 52 weeks +36.7% NSYS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ENSC|Ensysce Biosciences Inc|Price:0.255|Chg%:-0.006

TradingKey provides a comprehensive stock analysis for Ensysce Biosciences Inc (ENSC), highlighting its strong fundamentals, high growth potential, and relatively fair valuation within the Biotechnology & Medical Research industry. Despite a recent weak stock market performance and institutional selling, analysts have a high price …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026

Jeffrey Millard, the Chief Operating Officer of Ensysce Biosciences, has resigned from his position, with the resignation becoming effective on July 10, 2026. The reasons for his departure and details about his replacement have not been disclosed. This information is based on an SEC …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

COO Jeffrey Millard exits Ensysce Biosciences (Nasdaq: ENSC) July 10

Jeffrey Millard resigned from his position as Chief Operating Officer of Ensysce Biosciences (Nasdaq: ENSC), effective July 10, 2026. The company officially reported this material event via an 8-K filing on July 15, 2026. Ensysce Biosciences emphasizes its status as an emerging growth company, …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce receives $5.3M NIDA award for opioid overdose therapy By Investing.com

Ensysce Biosciences (NASDAQ: ENSC) has received a $5.3 million award from the National Institutes on Drug Abuse (NIDA) to advance its MPAR overdose-protection technology, specifically for its lead agent PF614-MPAR. This funding, part of a total $15.1 million support over three years, will facilitate …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant

Ensysce Biosciences has received the final $5.3 million installment of a $15.1 million federal grant from the National Institutes on Drug Abuse (NIDA). This funding will advance the development of PF614-MPAR, a novel opioid with oral overdose protection that has received FDA Breakthrough Therapy …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Ensysce Biosciences Awarded $5.3 Million To Advance Overdose-Protected Opioid

Ensysce Biosciences has received a $5.3 million installment from the National Institute on Drug Abuse (NIDA), completing a multi-year federal grant of approximately $15.1 million. This funding will support the continued nonclinical and clinical development of PF614-MPAR, a first-in-class opioid designed with MPAR overdose-protection …

ENSC main company
Sharemaestro market context Price below Trend Line 52 weeks -80.5% · Next-week setup negative 37.7% ENSC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context